 |
인쇄하기
취소
|
Vaccines make Green Cross No. 1 drugmaker
Green Cross Corporation became the first biggest drug manufacturer in Korea in terms of quarterly revenue, as the outbreak of influenza A boosted demand for seasonal flu vaccines, according to Yakup Shinmoon.
Green Cross posted revenue of 286.8 billion won in the first quarter, while Dong-A Pharmaceutical came in second with 201 billion won.
“The significant rise in sales resulted from so...
Green Cross posted revenue of 286.8 billion won in the first quarter, while Dong-A Pharmaceutical came in second with 201 billion won.
“The significant rise in sales resulted from so...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.